Download


Glycosylated Haemoglobin (HbA1c)
Investigation Result Units Biological Reference Interval

Glycosylated Haemoglobin(HBA1C) 4.6 % Non-diabetic adults>=18 years <5.7
At risk (Pre-diabetes) 5.7-6.4
Diagnosing Diabetes >=6.5
Therapeutic goals for glycemic control
Age> 19 years:< 7
For Age< 19 year:< 7.5


.
Mean Blood Glucose 85.32 mg/dl
Sample Type : EDTA Whole Blood.
Method : High-performance liquid chromatogrphy.

Interpretations: Since HbA1c reflects long term fluctuations in the blood glucose concentration, a diabetic patient who is recently under good control may still have a high concentration of HbA1c. Converse is true for a diabetic previously under good control but now poorly controlled . Target goals of < 7.0 % may be beneficial in patients with short duration of diabetes, long life expectancy and no significant cardiovascular disease. In patients with significant complications of diabetes, limited life expectancy or extensive co-morbid conditions, targeting a goal of < 7.0 % may not be appropriate. Comments: HbA1c provides an index of average blood glucose levels over the past 8 - 12 weeks and is a much better indicator of long term glycemic control as compared to blood and urinary glucose determinations Disclaimer: The above result relate only to the specimens received and tested in laboratory and should be always correlate with clinical findings and other laboratory markers. Improper specimen collection, handling, storage and transportation may result in false negative/Positive results. Disclaimer : 1) The above result relate only to the specimens received and tested in laboratory and should be always correlate with clinical findings and other laboratory markers. 2) Improper specimen collection, handling, storage and transportation may result in false negative/Positive results.

--End Of Report--
Iron Studies (Iron, TIBC, TS %)
Investigation Result Units Biological Reference Interval

Iron 72.83 ug/dl 37 - 145
• Sample Type : Serum.
• Method : Colorimetric assay.
Total Iron Binding Capacity 406 ug/dl 265 - 497
• Sample Type : Serum.
• Method : Iron Saturation/Dye Binding.
Transferrin Saturation 17.94 % 15 - 50

Comments : Iron is an essential trace mineral element which forms an important component of hemoglobin, metallocompounds and Vitamin A. Deficiency of iron,leads to microcytic hypochromic anemia. The toxic effects of iron are deposition of iron in various organs of the body and hemochromatosis. Total Iron Binding capacity (TIBC) is a direct measure of the protein Transferrin which transports iron from the gut to storage sites in the bone marrow. In iron deficiency anemia, serum iron is reduced and TIBC increases. Transferrin Saturation occurs in Idiopathic hemochromatosis and Transfusional hemosiderosis where no unsaturated iron binding capacity is available for iron mobilization. Similar condition is seen in congenital deficiency of Transferrin. Disclaimer : 1) The above result relate only to the specimens received and tested in laboratory and should be always correlate with clinical findings and other laboratory markers. 2) Improper specimen collection, handling, storage and transportation may result in false negative/Positive results.

--End Of Report--
Thyroid Function Test (TFT)
Investigation Result Units Biological Reference Interval

T3 (Triiodothyronine) 1.09 ng/mL 0.8 - 2.0
• Sample Type : Serum.
• Method : ECLIA.
T4 (Thyroxine) 8.33 ug/dl 5.1 - 14.1
• Sample Type : Serum.
• Method : ECLIA.
ULTRA Thyroid Stimulating Hormone (TSH) 3.48 uIU/mL 0.27 - 4.2
Frist trimester: 0.3- 4.5
Second trimester : 0.5 -4.6
Third trimester : 0.8 -5.2
• Sample Type : Serum.
• Method : ECLIA.

1) TSH levels are subject to circadian variation, reaching peak levels between 2 - 4.a.m. and at a minimum between 6-10 pm. The variation is of the order of 50% . hence time of the day has influence on the measured serum TSH concentrations. 2) Recommended test for T3 and T4 is unbound fraction or free levels as it is metabolically active. 3) Physiological rise in Total T3 / T4 levels is seen in pregnancy and in patients on steroid therapy. Clinical Use : • Primary Hypothyroidism • Hyperthyroidism • Hypothalamic – Pituitary hypothyroidism • Inappropriate TSH secretion • Nonthyroidal illness • Autoimmune thyroid disease • Pregnancy associated thyroid disorders. • References : - Henry’s Clinical Diagnosis and Management, 23rd edition. -Tietz Fundamentals of Clinical Chemistry and Molecular Diagnosis, 7th edition. •Disclaimer: 1) The above result relate only to the specimens received and tested in laboratory and should be always correlate with clinical findings and other laboratory markers. 2) Improper specimen collection, handling,storage and transportation may result in false negative/Positive results.

--End Of Report--